{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:42:23Z","timestamp":1758588143449,"version":"3.44.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.transproceed.2022.01.025","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T08:30:40Z","timestamp":1646814640000},"page":"930-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Malignancy Prevalence in the Dialyzed Population and in Waitlisted Potential Kidney Transplant Recipients"],"prefix":"10.1016","volume":"54","author":[{"given":"Micha\u0142","family":"Pyr\u017ca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"G\u0142ogowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Wieliczko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"\u017bebrowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wojtaszek","family":"Ewa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Semeniuk-Wojta\u015b","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafa\u0142","family":"Stec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u0142awomir","family":"Nazarewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-8171","authenticated-orcid":false,"given":"Jolanta","family":"Ma\u0142yszko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2022.01.025_bib0001","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: an international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0002","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000445362","article-title":"Cancer incidence and mortality in chronic dialysis population: a multicenter cohort study","volume":"43","author":"Cheung","year":"2016","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0003","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/ndt\/gfv007","article-title":"Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry","volume":"30","author":"Vogelzang","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0004","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1744-9987.2012.01144.x","article-title":"Cause-specific excess mortality among dialysis patients: comparison with the general population in Japan","volume":"17","author":"Wakasugi","year":"2013","journal-title":"Ther Apher Dial"},{"issue":"Suppl","key":"10.1016\/j.transproceed.2022.01.025_bib0005","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.3346\/jkms.2009.24.S1.S95","article-title":"Cancer in patients on chronic dialysis in Korea","volume":"24","author":"Lee","year":"2009","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0006","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/TP.0000000000003136","article-title":"KDIGO clinical practice guideline on the evaluation and management of candidates for kidney transplantation","volume":"104","author":"Chadban","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0007","first-page":"1380","article-title":"Effect of immunosuppression on preexisting cancers","volume":"25","author":"Penn","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0008","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1432-2277.2005.00109.x","article-title":"Prevalence of cancer history prior to renal transplantation","volume":"18","author":"Fischereder","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0009","first-page":"147","article-title":"Occurrence of cancers in immunosuppressed organ transplant recipients","author":"Penn","year":"1998","journal-title":"Clin Transpl"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0010","doi-asserted-by":"crossref","first-page":"21398","DOI":"10.1038\/s41598-020-78283-5","article-title":"Incidence of malignancy and related mortality after kidney transplantation: a nationwide, population-based cohort study in Korea","volume":"10","author":"Jeong","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0011","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242805","article-title":"De-novo malignancies after kidney transplantation: A long-term observational study","volume":"15","author":"Fr\u00f6hlich","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0012","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/sj.ki.5002154","article-title":"The janus face of immunosuppression\u2014de novo malignancy after renal transplantation: the experience of the Transplantation Center Munich","volume":"71","author":"Wimmer","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0013","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.kint.2020.10.018","article-title":"Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period","volume":"99","author":"Blosser","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0014","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/ndt\/gfaa109","article-title":"Cancer survival in kidney transplant recipients in Ireland","volume":"35","author":"Murray","year":"2020","journal-title":"Nephrol Dial Transplant"},{"year":"2019","series-title":"2019 USRDS annual data report: epidemiology of kidney disease in the United States","key":"10.1016\/j.transproceed.2022.01.025_bib0015"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0016","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ki.2014.419","article-title":"Development and validation of a predictive mortality risk score from a European hemodialysis cohort","volume":"87","author":"Floege","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0017","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/ndt\/gfx355","article-title":"Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe-data from the ERA-EDTA Registry","volume":"33","author":"Ceretta","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0018","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.ejca.2014.01.027","article-title":"The European Cancer Observatory: a new data resource","volume":"51","author":"Steliarova-Foucher","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0019","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/ndt\/gfq845","article-title":"Effects of comorbid and demographic factors on dialysis modality choice and related patient survival in Europe","volume":"26","author":"van de Luijtgaarden","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1159\/000186652","article-title":"Incidence and mortality patterns of malignancy and factors affecting the risk of malignancy in dialysis patients","volume":"59","author":"Inamoto","year":"1991","journal-title":"Nephron"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0021","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0272-6386(89)80187-8","article-title":"Neoplasms in dialysis patients: a population-based study","volume":"14","author":"Port","year":"1989","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0022","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000504243","article-title":"Incidence, risk, and prognosis of cancer in patients on chronic hemodialysis","volume":"49","author":"Chen","year":"2020","journal-title":"Blood Purif"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0023","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s12882-019-1578-5","article-title":"Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study","volume":"20","author":"Chinnadurai","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0024","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s40620-019-00649-4","article-title":"Distribution and association of cancer with mortality in end-stage renal disease patients receiving dialysis","volume":"32","author":"Chinnadurai","year":"2019","journal-title":"J Nephrol"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12882-019-1283-4","article-title":"Increased cancer risk in patients undergoing dialysis: a population-based cohort study in north-eastern Italy","volume":"20","author":"Taborelli","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0026","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","article-title":"Cancer incidence before and after kidney transplantation","volume":"296","author":"Vajdic","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0027","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000013314","article-title":"Cancer in end-stage renal disease: potential factors involved","volume":"18","author":"Vamvakas","year":"1998","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0028","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/iju.13759","article-title":"Renal tumors in end-stage renal disease: a comprehensive review","volume":"25","author":"Tsuzuki","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0029","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0272-6386(95)90544-8","article-title":"Urologic cancers in uremic patients","volume":"25","author":"Chen","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0030","first-page":"2018","article-title":"Renal cell carcinoma and end stage renal disease","volume":"2006","author":"Farivar-Mohseni","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0031","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000281722","article-title":"Cancer incidence in patients on chronic dialysis and in renal dialysis patients","volume":"45","author":"Pecqueux","year":"1990","journal-title":"Urol Int"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0032","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0140-6736(86)91407-8","article-title":"Renal cell carcinoma, a new complication of analgesic nephropathy","volume":"327","author":"Lornoy","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0033","first-page":"3468","article-title":"Impairment of DNA repair in the course of long-term hemodialysis and under cyclosporine immunosuppression after renal transplantation","volume":"28","author":"Vamvakas","year":"1996","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0034","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/ki.1993.256","article-title":"DNA repair and recovery of RNA synthesis in uremic patients","volume":"44","author":"Malachi","year":"1993","journal-title":"Kidney Int"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0035","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000189042","article-title":"Plasma glutathione peroxidase deficiency caused by renal dysfunction","volume":"73","author":"Nomura","year":"1996","journal-title":"Nephron"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0036","first-page":"162","article-title":"Increased risk of malignancy and blood-membrane interactions in uraemic patients","volume":"9","author":"Akizawa","year":"1994","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0037","first-page":"S37","article-title":"The immune status of the uremic patient: hemodialysis vs CAPD","volume":"30","author":"Schollmeyer","year":"1988","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0038","first-page":"253","article-title":"Chronic kidney disease and cancer: a troubling connection","volume":"23","author":"Stengel","year":"2010","journal-title":"J Nephrol"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0039","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0040","doi-asserted-by":"crossref","first-page":"66601","DOI":"10.18632\/oncotarget.18094","article-title":"Cancer and the kidney: dangereoux liasons or price paid for the progress in medicine?","volume":"8","author":"Ma\u0142yszko","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0041","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.transproceed.2020.01.119","article-title":"Malignancy prevalence in waitlisted potential kidney transplant recipients is very low relative to patients after kidney transplantation","volume":"52","author":"Pyr\u017ca","year":"2020","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2022.01.025_bib0042","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/ndt\/gfz026","article-title":"Pre-existing malignancies in renal transplant candidates-time to reconsider waiting times","volume":"34","author":"Watschinger","year":"2019","journal-title":"Nephrol Dial Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522001208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134522001208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:44:29Z","timestamp":1758577469000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134522001208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0041134522001208"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.01.025","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Malignancy Prevalence in the Dialyzed Population and in Waitlisted Potential Kidney Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2022.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}